Atypical Trigeminal Neuralgia — When Facial Pain Treatment Fails

Author: Dr. Zeljko Kojadinovic, MD, PhD – Neurosurgeon and Pain Management Specialist

Last medically reviewed: June 10, 2026

Why facial pain treatment fails in atypical trigeminal neuralgia

Facial pain treatment often fails because the diagnosis is treated as a label instead of a mechanism.

Many patients are told they have trigeminal neuralgia and are then treated according to the standard protocol for typical trigeminal neuralgia. This usually means carbamazepine or oxcarbazepine first, followed by consideration of microvascular decompression, Gamma Knife, rhizotomy, or repeated nerve procedures if the pain continues.

That approach can work very well in classical trigeminal neuralgia. It is much less reliable when the pain is atypical.

Atypical trigeminal neuralgia may cause constant burning, aching, pressure, tooth-like pain, jaw pain, cheek pain, pain around the eye, ear-region pain, post-dental pain, postherpetic pain, or pain that continues between attacks. In these patients, the active problem may be outside the classical root-entry-zone vascular compression site — the part of the trigeminal nerve located inside the skull, close to the brainstem, where a blood vessel typically compresses the nerve in classical trigeminal neuralgia.

The irritation may involve any peripheral branch of the trigeminal nerve in the face. Possible causes include dental-related nerve injury, scar tissue, inflammation, viral nerve damage, muscle spasm, TMJ-related irritation, local compression, other pain-contributing factors, or central sensitization. If these mechanisms are not identified, treatment becomes incomplete.

Listen to the YouTube audio explanation on the diagnosis and treatment of refractory trigeminal neuralgia explained by the author.

Image: Nerves that innervate skin of the head and face This image shows the main sensory nerves of the head and face. The most important facial pain pathways are the trigeminal branches: V1, V2, and V3. V1 is the ophthalmic branch and supplies the forehead, upper eyelid, eye region, and upper nose. V2 is the maxillary branch and supplies the cheek, lower eyelid, side of the nose, upper lip, upper teeth, and upper gum. V3 is the mandibular branch and supplies the lower jaw, lower teeth, lower gum, chin, part of the tongue, and part of the ear-temple region. The smaller labels show peripheral branches of these nerves. SON-S means supraorbital nerve, superficial branch. SON-D means supraorbital nerve, deep branch. STN means supratrochlear nerve. ZTN means zygomaticotemporal nerve. AT means auriculotemporal nerve. These smaller branches can become irritated locally and may produce focal forehead, temple, eye-region, cheek, jaw, or ear-temple pain even when routine MRI does not show a clear cause. Read more about the anatomy of the cranial nerves here

Why pain may continue even after microvascular decompression

Microvascular decompression is most effective when the patient has classical trigeminal neuralgia: brief electric-shock attacks, clear trigger zones, pain-free intervals, good response to carbamazepine or oxcarbazepine, and MRI evidence of vascular compression that matches the symptoms.

When facial pain is constant, burning, atypical, post-dental, postherpetic, bilateral, poorly responsive to medication, or not clearly matched by MRI, MVD becomes less predictable.

If pain continues after MVD, several explanations are possible. The vascular contact may not have been the true pain generator. There may have been a second mechanism active at the same time. The pain may come from a peripheral trigeminal branch in the face. The nervous system may have become sensitized after long-standing pain. Dental, viral, muscular, TMJ-related, or scar-related factors may still be irritating the nerve.

For this reason, persistent pain after MVD should not automatically lead to another destructive procedure. The first step should be a structured reassessment of the pain mechanism.

Image: Three facial regions where pain can occur, either separately or in combination

Why MRI can be normal in atypical trigeminal neuralgia

MRI is important in facial pain because it can detect tumors, multiple sclerosis, vascular compression, and other secondary causes. However, MRI cannot show every clinically important source of trigeminal nerve irritation.

Many causes of atypical trigeminal neuralgia are too small, too functional, or too peripheral to be clearly visible on routine imaging. A small irritated nerve branch in the face, scar tissue after dental work, local inflammation, muscle spasm, trigger-zone hypersensitivity, postherpetic nerve injury, or early peripheral nerve sensitization may not appear as a clear MRI abnormality.

A normal MRI does not mean that the pain is imaginary. It means that the diagnosis must rely more heavily on pain anatomy, clinical pattern, trigger analysis, response to previous treatment, and functional testing.

The most useful question is not only “what does the MRI show?” The more important question is: does the imaging explain the exact pain pattern?

How the true trigeminal pain generator is identified

The true trigeminal pain generator is identified by combining medical history, facial pain anatomy, trigger analysis, imaging review, and guided functional examination. The goal is not only to confirm the label “trigeminal neuralgia,” but to understand where and how the nerve is being irritated and why standard treatment has failed.

During the consultation, the pain pattern is analyzed in detail. It is important to determine where the facial pain starts, where it spreads, whether it feels electric, burning, aching, stabbing, pressure-like, dental-like, or deep, and whether there are pain-free intervals between attacks. The doctor also evaluates whether chewing, talking, brushing teeth, shaving, cold wind, jaw movement, pressure on certain points of the face and mouth, or neck movement changes the pain.

The previous history is equally important. Facial pain that began after dental treatment, facial trauma, shingles, herpes outbreaks, surgery, infection, or a previous procedure may have a different mechanism from typical trigeminal neuralgia. The response to carbamazepine, oxcarbazepine, nerve blocks, Gamma Knife, rhizotomy, or microvascular decompression also helps show whether the pain behaves like classical TN or whether another pain generator is active.

An examination of a patient with trigeminal neuralgia can be conducted in person at the clinic or during a video consultation. During a video consultation, the patient can be guided to press specific points on the face, jaw, cheek, temple, forehead, gum region, or around the eye. The patient may also be asked to perform small jaw, neck, or facial movements. If pain increases, decreases, spreads, or changes quality, this can help localize the irritated trigeminal branch or contributing structure.

This is not a general conversation. It is an anatomical pain-mapping process. In atypical trigeminal neuralgia, this step is often more important than simply repeating MRI interpretation, because the active irritation may be located in a small peripheral branch of the nerve in the face and may not be visible on standard imaging.

Why knowledge of facial pain anatomy matters

Atypical trigeminal neuralgia cannot be understood only by naming the diagnosis. The trigeminal nerve has several branches, and each branch can create a different pain pattern.

Pain around the eye, forehead, temple, upper teeth, cheek, nose, lower teeth, jaw, chin, ear region, tongue, or gum may involve different trigeminal pathways. Some pains are caused by the nerve root near the brainstem. Others are caused by peripheral branches in the face. Some are mixed with TMJ, muscle, cervical, dental, postherpetic, or central sensitization mechanisms.

If the anatomical source is not identified, treatment is often too general. A single medication may reduce nerve excitability but fail to stop ongoing local irritation. A procedure may interrupt one pathway but miss the true trigger point. Surgery may be performed for vascular contact that does not actually explain the symptoms.

Successful treatment depends on matching the treatment to the mechanism.

Common mechanisms behind persistent atypical facial pain

Atypical trigeminal neuralgia and persistent facial pain are often maintained by more than one mechanism at the same time. This is one of the main reasons why standard treatment may fail. A patient may have a partial vascular contact on MRI, but the active pain generator may still be in a peripheral trigeminal branch, a dental-related nerve injury, scar tissue, muscle spasm, viral nerve damage, or central sensitization.

Peripheral trigeminal branch irritation may involve the main trigeminal branches but also supraorbital, infraorbital, mental, alveolar, auriculotemporal, or other smaller branches of the trigeminal nerve. These irritations are often very small and may not be visible on routine MRI, but they can produce severe facial pain when the affected branch becomes hypersensitive.

Post-dental trigeminal nerve pain may appear after tooth extraction, root canal treatment, dental implants, local infection, prolonged jaw opening, or repeated dental procedures. In these cases, the patient may continue to feel tooth-like or gum-region pain even when the tooth itself is no longer the source of the problem.

Postherpetic or herpes-related trigeminal pain may follow shingles or recurrent herpes outbreaks, even after the skin lesions have healed. Viral injury can sensitize the trigeminal nerve or one of its branches, causing burning, hypersensitivity, electric pain, or pain triggered by light touch.

Muscle and TMJ-related irritation may amplify trigeminal pain through chewing muscles, jaw mechanics, bruxism, clenching, or referred pain. These factors may not be the only cause, but they can maintain irritation and make trigeminal nerve pain harder to control.

Scar tissue and local inflammation may irritate small nerve branches after trauma, surgery, dental procedures, infection, or chronic tissue irritation. This type of local pain generator is often missed because it may be too small to appear clearly on imaging.

Central sensitization may develop after long-standing facial pain. The nervous system becomes more reactive, and normal touch, chewing, cold wind, or mild pressure may start to feel painful. This does not mean the pain is psychological. It means that the pain system has become hypersensitive.

Mixed mechanisms are common in persistent atypical facial pain. Treating only one factor may give partial or temporary relief, but long-term improvement usually requires identifying the dominant pain generator and correcting the additional mechanisms that keep the trigeminal nerve irritated.

Contributing factors that can keep atypical trigeminal neuralgia active

In atypical trigeminal neuralgia, treatment often fails not only because the primary pain generator is missed, but also because additional pain-contributing factors are not recognized. These factors may not be the main cause of facial pain, but they can maintain trigeminal nerve irritation, increase nerve sensitivity, delay recovery, and reduce the effect of otherwise appropriate treatment.

The most important contributing factors include previous dental or facial procedures, chronic irritation of peripheral trigeminal branches, muscle tension, TMJ dysfunction, jaw clenching or bruxism, scar tissue, local inflammation, viral nerve injury, sleep disturbance, metabolic or inflammatory conditions, nutritional deficiencies, medication effects, and central sensitization. Therefore, patients must undergo a comprehensive diagnostic protocol, which is often neglected in cases of trigeminal neuralgia due to a lack of awareness regarding its importance in detecting factors that provoke and sustain facial pain.

This does not mean that every patient has all of these factors. The purpose of assessment is to identify which of them are actually active in that patient. Treating only one part of the problem — for example only increasing medication, repeating dental procedures, or focusing only on MRI findings — often gives incomplete or temporary relief.

A more effective approach is to identify the dominant trigeminal pain generator and then correct the contributing factors that keep the nerve irritated. This is why treatment usually requires a carefully selected combination of medication, dose adjustment, trigger control, sleep and metabolic correction when relevant, and sometimes targeted nerve blocks or interventional procedures.

Many patients have already tried one part of this strategy — medication, supplements, physiotherapy, dental treatment, diet changes, or injections — but not the complete mechanism-based approach. This is one of the common reasons why atypical trigeminal neuralgia becomes persistent.

Treatment when standard trigeminal neuralgia therapy has failed

When atypical trigeminal neuralgia does not improve, treatment should not simply repeat the same protocol. The first step is to separate the active mechanisms.

Once the pain generator and contributing factors are identified, treatment usually starts with a targeted combination of medications. This may include sodium-channel blockers, gabapentinoids, baclofen, antidepressants for neuropathic pain, topical treatments, anti-inflammatory support, sleep regulation, and, when clinically appropriate, medications targeting viral or inflammatory mechanisms, as well as various other therapies and procedures.

The goal is not to use many drugs randomly. The goal is to choose a logical combination that covers the mechanisms present in that patient.

Medication often has to be adjusted during the first 6–8 weeks. The first 10 days are especially important because early response, side effects, sedation, dizziness, mood change, sleep quality, and pain pattern changes help guide correction of the plan.

When the correct combination is found and pain remains controlled for 6–8 weeks, the effect is often more stable. In many patients, this avoids another major procedure.

When nerve blocks, Botox, or interventional treatment may help

Interventional treatment may help when medication alone is not enough or when the doctor needs to confirm the pain generator.

A selective nerve block can temporarily numb a suspected trigeminal branch. If the pain improves after a precisely targeted block, this gives diagnostic information and may also help break the pain cycle.

Botulinum toxin may help some patients with persistent burning or hypersensitive trigeminal pain, especially when pain is superficial, branch-related, or associated with trigger zones.

Image-guided procedures may be considered when the pain source is small, deep, or close to important anatomical structures. These procedures should be selected according to the exact pain generator, not only according to the diagnosis name.

Gamma Knife, rhizotomy, Gasserian ganglion procedures, or repeat surgical opinions may still be appropriate in selected cases, but they should be considered only after the pain mechanism has been reassessed.

Image: Interventional pain procedure used in trigeminal neuralgia treatment

Can atypical trigeminal neuralgia improve after many years?

Yes. Long-lasting facial pain can still improve, but the treatment must be more precise than simply repeating the same medication or procedure.

When pain has been present for months or years, several mechanisms may be active at once. The nerve may be irritated locally. The brainstem and central pain pathways may become sensitized. Muscles, jaw mechanics, dental history, viral injury, sleep problems, metabolic factors, and previous treatments may all influence the pain threshold.

This does not mean the pain is psychological. It means the pain system has become more reactive and requires a structured plan.

The most important question is not how long the pain has existed. The most important question is whether the real pain generator has ever been correctly identified and treated.

When to seek a second opinion

A second opinion is useful when facial pain continues despite standard trigeminal neuralgia treatment, when the diagnosis is uncertain, or when a major procedure has been recommended.

It is especially important if:

• the pain is constant, burning, aching, pressure-like, or dental-like rather than brief electric shocks only;
• MRI is normal, unclear, or does not match the exact pain pattern;
• carbamazepine, oxcarbazepine, gabapentin, pregabalin, or other medications helped only briefly, partially, or caused limiting side effects;
• pain continued after microvascular decompression, Gamma Knife, rhizotomy, nerve blocks, or other procedures;
• repeated dental treatments, tooth extraction, root canal treatment, or implants did not solve the pain;
• doctors disagree about whether the pain is typical trigeminal neuralgia, atypical trigeminal neuralgia, TMJ pain, dental pain, trigeminal neuropathy, postherpetic pain, or central sensitization;
• another procedure has been recommended, but the true pain generator has not been clearly identified.

The purpose of a second opinion is not only to decide whether surgery is needed. The main purpose is to identify the active pain generator, understand why previous treatment failed, and choose the safest logical next step.

Online consultation for atypical trigeminal neuralgia

An online consultation can be useful in atypical trigeminal neuralgia because the diagnosis depends heavily on pain pattern, triggers, anatomical distribution, and response to guided functional testing.

Before the consultation, previous MRI, CT, dental reports, operative reports, medication history, and procedure results are reviewed. During the video call, the patient describes the pain in detail and is guided through simple pressure and movement tests.

The goal is to answer three practical questions:

• What is the most likely source of trigeminal nerve irritation?
• Which mechanisms are keeping the facial pain active?
• Which treatment path is most logical now: medication adjustment, targeted combination therapy, nerve block, Botox, interventional procedure, surgery review, or observation?

In many cases, one to three consultations are enough to identify the pain generator, start treatment, and adjust the plan during the first 6–8 weeks.

Prognosis of atypical trigeminal neuralgia when treatment has failed

The prognosis of atypical trigeminal neuralgia is different from the prognosis of classical trigeminal neuralgia because the pain mechanism is usually different.

In classical trigeminal neuralgia, carbamazepine or oxcarbazepine often provides strong initial pain control, commonly reported in the range of 70–90% in typical cases. However, long-term medication control is less stable, and many patients eventually need a procedure when medication loses effect or causes side effects. When classical TN is caused by MRI-confirmed vascular compression that matches the symptoms, microvascular decompression has the best long-term results, with many series reporting durable relief in approximately 70–80% of well-selected patients.

In atypical trigeminal neuralgia, the prognosis is less predictable. When pain is constant, burning, aching, post-dental, postherpetic, MRI-negative, or not clearly linked to vascular compression, response to standard medication and classical procedures is usually lower and less durable. In clinical practice and reported series, meaningful improvement with medication-based treatment is often closer to 30–50%, while stable long-term control with medication alone may be closer to 20–30% in difficult continuous-pain cases. These numbers should be understood as approximate clinical ranges, not as fixed outcomes for every patient.

The prognosis improves when treatment is based on the true pain generator rather than only on the diagnosis name. Patients usually do better when peripheral trigeminal branch irritation, post-dental nerve injury, viral nerve injury, scar tissue, local inflammation, muscle or TMJ-related factors, and central sensitization are identified separately and treated together.

When the source of irritation is localized, a targeted combination of medications can often reduce pain during the first 10 days, with further adjustment over 6–8 weeks. If pain remains controlled for 6–8 weeks, the effect is often more stable and the need for another major procedure may decrease.

Selective nerve blocks, Botox, or image-guided procedures may help when medication alone is not enough or when the pain generator needs confirmation. In atypical trigeminal neuralgia, these procedures are most useful when they are directed at a clearly identified branch, trigger zone, or local source of irritation.

Procedures such as Gamma Knife, rhizotomy, Gasserian ganglion procedures, or repeat surgical review may still be appropriate in selected cases, but results are generally less predictable when pain is continuous, MRI does not show clinically meaningful vascular compression, or the pain pattern does not match classical trigeminal neuralgia. In such non-classical cases, the goal is often not complete remission from one procedure, but significant pain reduction and stable control.

Typical trigeminal neuralgia often aims for remission. Atypical trigeminal neuralgia usually aims for control. Success depends mainly on identifying the exact source of irritation and correcting the mechanisms that keep the trigeminal nerve active.

Online pain consultation for atypical trigeminal neuralgia in detail

Schematic explanation of the video consultation for atypical trigeminal neuralgia

Answers to questions about the process and success of video consultations for atypical trigeminal neuralgia

See the page “Possible Reasons for Poor Pain Treatment Effectiveness of Atypical Trigeminal Neuralgia” for an explanation of why conventional chronic pain treatments often fail—and what we do differently.

Treatment of complex cases of trigeminal neuralgia can be analysed by artificial intelligence (AI)